SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Clinical trial NCT01352520 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01352520
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma Lymphoma, Primary Cutaneous Anaplastic Large Cell Lymphomatoid Papulosis Mycosis Fungoides Skin Lymphoma Cutaneous Lymphomas Lymphoma Hematologic Disorder

Start date: 2011-06-01
Primary completion: 2028-01-31
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.